Compare Koninklijke Philips NV (PHG) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Invesco S&P 500 Momentum ETF — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Invesco S&P 500 Momentum ETF trades at $149.91. The key difference: Koninklijke Philips NV pays a 3.81% dividend while Invesco S&P 500 Momentum ETF pays none, and Invesco S&P 500 Momentum ETF is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| PHG | SPMO | |
|---|---|---|
Market Cap | $25.89B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $32.91 | $161.66 |
52-Week Low | $25.02 | $107.84 |
Enterprise Value | $32.18B | — |
Dividend Yield | 3.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
SPMO trades at $144.50, up 0.42% on the day, with a technical outlook leaning bearish based on moving averages despite neutral oscillators. The ETF has demonstrated strong momentum performance in 2026, with a 26% year-to-date return as of July 20, 2026 (247 Wallst). It maintains a concentrated, tech-heavy portfolio, heavily weighted toward AI beneficiaries, driving its outperformance versus the S&P 500.
Outlook remains positive for momentum-driven gains, supported by AI-fueled growth, but risks include high volatility and sensitivity to sector rotations. The upcoming $0.25 dividend in June 2026 provides additional shareholder return. Analyst sentiment is generally constructive, though the concentrated portfolio demands caution during market downturns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Invesco S&P 500 Momentum ETF
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →
